Rubicon Research Q3 FY26: Revenue up 52%, PAT up 91% YoY post-IPO

Revenue Growth 20pctPat Growth 25pctEmphasis Of MatterResults View source PDF Explain this filing

RUBICON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.5%Reaction day

₹725.00

prior close

₹735.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.3%+6.2% vs market

Pharmaceuticals peers, median of 155sector+0.2%+7.3% vs sector

On the reaction day the stock moved 6.2 pts more than Nifty Microcap 250 and 7.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+1.8

15m

+7.2

30m

+5.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.5+1.3+6.2+0.2+7.3

Next day

+8.3+0.3+8.0-0.4+8.6

+8.0-0.5+8.5-1.1+9.2

+8.2+2.1+6.1+0.7+7.5

+8.7+3.1+5.6+1.3+7.4

+7.8+2.6+5.2+1.4+6.4

+8.3+0.6+7.7+0.3+8.0

15d

+7.8-1.4+9.2-2.6+10.4

+4.1-6.9+11.1-5.1+9.2

+6.9-7.7+14.6-7.9+14.9

+34.4+7.0+27.5+0.7+33.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Rubicon Research posted strong Q3 FY26 results. Consolidated revenue rose 52% YoY to Rs 475.5 crore, with net profit up 91% at Rs 72.8 crore. Nine-month revenue grew 34% to Rs 1,240 crore, PAT up 73% at Rs 170 crore. Company listed on NSE and BSE in October 2025 after a Rs 1,377.5 crore IPO. Of net IPO proceeds of Rs 471.3 crore, Rs 252.1 crore was used to repay borrowings. Auditor flagged a post-quarter GST inspection at premises; no financial impact identified yet.

Likely market impact

Strong growth post-listing boosts investor confidence. GST inspection is a watch item but no adjustment needed so far. Expansion via Saudi subsidiary and overseas investments underway.